Results 91 to 100 of about 12,483 (137)

Solution to Problem 3307

open access: yes, 2009
Fernández, Emilio   +3 more
core  

Uniconazole (S-3307) strengthens the growth and cadmium accumulation of accumulator plantMalachium aquaticum

open access: yesInternational Journal of Phytoremediation, 2017
The effects of uniconazole (S-3307) application on the growth and cadmium (Cd) accumulation of accumulator plant Malachium aquaticum (L.) Fries. were studied through a pot experiment.
Jing He, Ming'An Liao, Yunsong Lai
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Abstract 3307: A novel targeted RNA sequencing approach for identification of aggressive prostate cancer

Cancer Research, 2023
Introduction: Prostate cancer (PC) is a highly heterogeneous disease and can be either aggressive, requiring immediate treatment, or remain slow growing and even without treatment present no significant symptoms throughout the man’s life.
Jacob Fredsøe   +5 more
semanticscholar   +1 more source

Abstract 3307: Multiomics analysis to uncover the mechanism of radiosensitization of AR-positive triple negative breast cancers with AR inhibition

Cancer Research, 2022
Purpose: Expression of the androgen receptor (AR) has been identified as a driver of tumor growth in triple negative breast cancers (TNBC), and previous work has nominated AR inhibition as a strategy for radiosensitization in AR+ TNBC. Despite its role
A. Michmerhuizen   +10 more
semanticscholar   +1 more source

Abstract 3307: Induction of autophagy as a mechanism of therapeutic resistance in head and neck cancer

open access: yes, 2017
Background: In the curative setting for head and neck cancer (HNC) a commonly used treatment is radiation combined with the anti-EGFR monoclonal antibody cetuximab (CTX).
Jaimee C. Eckers   +5 more
semanticscholar   +2 more sources

Abstract 3307: Real-world outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic non-small cell lung cancer (NSCLC)

Epidemiology, 2019
Introduction Pembrolizumab monotherapy was approved in October 2016 for first-line (1L) treatment of metastatic NSCLC with PD-L1 tumor proportion score (TPS) ≥50% based on KEYNOTE-024 (KN024) trial results.
V. Velcheti   +4 more
semanticscholar   +1 more source

Abstract 3307: BRCA1 promoter methylation analyzed in 1032 primary breast cancers predicts favorable response to chemotherapy independently of p53 mutations

Molecular and Cellular Biology / Genetics, 2018
Individuals with germline mutations in the breast cancer susceptibility gene, BRCA1, are at increased risk of developing breast- and ovarian cancer. BRCA1 is involved in DNA double strand break repair (DSB) by homologous recombination (HR), an error-free
Olafur A. Stefansson   +7 more
semanticscholar   +1 more source

Abstract 3307: Utilizing endocytosis as a predictive biomarker for ADCs

Cancer Research
Antibody drug conjugates (ADCs) consist of an antibody conjugated to a chemotherapeutic drug. These therapeutic compounds are designed to exert improved targeted toxicity as compared to conventional chemotherapy.
Anette Weyergang   +4 more
semanticscholar   +1 more source

Potential anti-apoptotic response in the induced T regulatory cells in the burn vs. burn-plus-peritonitis-injured animals 3307

Journal of Immunology
Actions of the mediators and cell-cell interactions presumably lead to the inhibition of the CD4+CD25- effector T cell proliferation and IL-2 production.
Nadeem Fazal
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy